The selective RET kinase inhibitor was cleared under the regulator’s accelerated approval process

The research funded will help inform policy decisions during the novel coronavirus pandemic

The Phase III IKEMA trial hit its primary endpoint

Around half of England’s population is now served by an ICS

University of Utah engineer is developing a fast, reusable test for COVID-19 that works with cellphones.

With severe blood disorders, such as leukemia, doctors often rely on leukapheresis, a procedure in which large machines […]

What you need to knowInterpreting the result of a test for covid-19 depends on two things: the accuracy […]

The moral fortitude of clinicians and health systems has been tested as the number of patients with covid-19 […]

The US currently carries the ignoble distinction of being the world leader in both incarceration and prevalence of […]

Stay alert for what?Covid-19, of course. In a curious move, Boris Johnson’s UK government has decided to ditch […]